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Kinetic constants were determined for the interaction of the HIV-2 aspartic proteinase with a synthetic substrate and 
a number of inhibitors at several pH values. Acetyl-pepstatin was more effective towards HIV-2 proteinase than the renin 
inhibitor, H-261; this effect is exactly the opposite from that observed previously for the proteinase from the HIV-1 AIDS 
virus. 
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1. INTRODUCTION 
The life cycle of  retroviruses including HIV,  the 
pathogen of  A IDS,  involves processing of  precur- 
sor gag and pol polyproteins into the mature vir ion 
components .  The proteolyt ic enzyme encoded by 
the virus which facil itates this processing thus 
becomes a potential  target for therapeutic in- 
tervent ion to b lock H IV  infection [1]. The crystal 
structure of  this enzyme from HIV-1 has been solv- 
ed at m~dium resolut ion [2] and molecular  model l -  
ing o f  its substrate-binding site [3] together with 
biochemical  studies with various inhibitors [4] 
have shown that the HIV-1 proteinase has the 
molecular  topography characteristics of an aspar- 
tic proteinase. 
The genomic organisat ion of  the HIV-2 virus 
has been determined [5] and the nucleotide se- 
quence of  the pol region in which the proteinase is 
encoded predicts that the proteinase will be 
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Abbreviations and convention: Iva, isovaleryl; Sta, 
4-amino-3-hydroxy-6-methylheptanoic cid; HIV, human im- 
munodeficiency virus; the * in the sequence containing Phe*Pro 
indicates the scissile peptide bond in the substrate 
homologous to but not identical with the cor- 
responding enzyme from HIV-1. It has been 
demonstrated that the proteinase from HIV-2 will 
catalyse the maturat ion  of  chimaeric H IV -1 /2  
polyproteins in an E. coli expression system [6] but 
otherwise, relatively little in format ion is avai lable 
concerning the enzyme from HIV-2.  Since it would 
clearly be desirable to attempt to develop pro- 
teinase inhibitors that would be effective against 
enzymes f rom different strains and species of  
virus, it was thus considered of  interest o examine 
in detai l  the susceptibi l ity of  proteinase from 
HIV-2 to a variety of  avai lable inhibitors of  aspar-  
tic proteinases. 
2. MATERIALS  AND METHODS 
The peptide substrate Tyr-Val-Ser-Gln-Asn-Phe*Pro-Ile-Val- 
Gln-Asn-Arg was synthesized as described previously [4]. 
Acetyl-pepstatin, lactoyl-pepstatin and H-261 were generously 
supplied by Dr K. Oda, Dr T. Aoyagi and Professor M. Szelke 
as detailed previously [4]. Purified HIV-1 proteinase was kindly 
provided by Dr Mary Graves (Roche Nutley, USA). 
E. coli containing the plasmid p2 PROT L [6] was grown at 
25°C and induced for 3 h with IPTG. HIV-2 proteinase was 
isolated from the soluble fraction obtained by lysing the cells 
with lysozyme and Tween-20 and purified by ammonium 
sulphate precipitation followed by chromatography on hydrox- 
yapatite and Sephadex G-75 (a fuller account will be described 
elsewhere). The proteinase thus obtained migrated as a single 
band (of apparent Mr 11000) on SDS-polyacrylamide g l elec- 
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Fig.1. SDS-PAGE electrophoresis. Samples from HIV-2 
proteinase purification were applied to a 20°70 Phast gel. Lanes: 
(1) extract after ammonium sulphate precipitation; (2) eluate 
from hydroxyapatite column; (3) G-75 fraction; (4) HIV-I 
proteinase; (5) molecular mass markers. 
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Table 1 
Kinetic constants for the hydrolysis of Tyr-Val-Ser-Gln-Asn- 
Phe*Pro-Ile-Val-Gln-Asn-Arg by HIV-2 proteinase at several 
pH values 
pH Km (,aM) kcat (s - l) 
4.7 160 1 
6.0 220 1 
7.0 - 4500 - 12 
trophoresis (fig. 1 - the HIV-2 enzyme appeared slightly smaller 
than the proteinase from HIV-I, consistent with the sequence 
data). 
Incubation of this purified HIV-2 proteinase with substrate 
was carried out at a variety of pH values and monitored by 
reverse-phase FPLC as described previously [4]. 
3. RESULTS AND DISCUSSION 
Kinetic parameters for the hydrolysis of Tyr- 
Val- Ser-Gln-Asn-Phe*Pro- Ile-Val-Gln-Asn-Arg 
were determined at several pH values (table 1). 
Values of kcat were derived from the equation Vmax 
= kcat" [E], (it was possible to derive values for [El 
by titration with acetyl-pepstatin, see below). As 
observed previously for HIV-1 proteinase [4], the 
values of Km diminished ramatically at pH 7.0, 
whereas the kcat value appeared to increase (an 
estimated value is given because saturation of the 
enzyme with substrate could not readily be achiev- 
ed at this pH). However, the value of Km (160/zM) 
determined for HIV-2 proteinase (at pH 4.7 for ex- 
ample) was approx. 2.5-fold higher than the cor- 
responding value reported previously [4] for the 
HIV-1 proteinase interaction with this substrate. 
Similarly, determination of ICs0 values for in- 
hibition of HIV-2 enzyme by isovaleryl-pepstatin 
(= Iva-Val-Val-Sta-Ala-Sta) nd lactoyl-pepstatin 
All measurements were Carried out at 30°C in buffers consisting 
of 0.1 M sodium acetate, pH 4.7; 0.02 M Mes, pH 6.0; 0.1 M 
Mes, pH 7.0, all containing 1 M NaCI (to keep the final ionic 
strengths the same) plus 4 mM EDTA and 5 mM 
mercaptoethanol. Samples were removed at 3 appropriate time 
points and quenched by addition of 5% (v/v) trifluoroacetic 
acid before analysis by RP-FPLC. The estimated precision of 
the values given is in the range _ 30% except at pH 7.0 
(= lactoyl-Val-Sta-Ala-Sta) under pH 4.7 condi- 
tions resulted in values of 150 and 750 nM being 
obtained, respectively. Again, these are slightly 
poorer than the corresponding values [4] for 
HIV-1 proteinase inhibition at pH 4.7 (100 and 
400 nM, respectively). The inhibition of HIV-2 en- 
zyme by both compounds was, however, much 
weaker at pH 7.0 (where ICso values of 1500 and 
16000 nM, respectively, were measured). 
It was reported previously that the acetyl- 
derivative of pepstatin ( -- Ac-Val-Val-Sta-Ala-Sta) 
was an effective inhibitor of HIV-1 enzyme [4] 
with a Ki value of 20nM at pH 4.7 (but of 
> 1000 nM at pH 7.0). Acetyl-pepstatin was an 
even better inhibitor of HIV-2 proteinase, binding 
sufficiently tightly for it to be used as an active site 
titrant with which to determine the active concen- 
tration of preparations of HIV-2 proteinase 
(fig.2). Inhibition constants for the HIV-2 interac- 
tion are summarised in table 2. 
In contrast, the renin inhibitor H-261 = tBoc- 
His-Pro-Phe-His-Leu~b[CHOH-CHz]Val-Ile-His 
was reported [4] to be a stronger inhibitor than 
acetyl-pepstatin of HIV-1 proteinase. Conversely, 
this was found to be a poorer inhibitor (than 
acetyl-pepstatin) towards HIV-2 enzyme (table 2). 
However, in complete contrast to the effect found 
previously with the HIV-1 proteinase, the potency 
of H-261 towar~is HIV-2 enzyme was not main- 
tained at pH 7.0. The inhibitory potency of acetyl- 
pepstatin at pH 7.0 diminished substantially 
towards HIV-2 enzyme (table 2), as was found 
previously with HIV-1 proteinase [4]. 
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Fig.2. Inhibition of HIV-2 proteinase by acetyl-pepstatin. 
HIV-2 proteinase was incubated with various concentrations of 
acetyl-pepstatin at a fixed concentration (127/zM) of substrate 
peptide in 100 mM sodium acetate buffer, pH 4.7, containing 
1 M NaC1, 4 mM EDTA, 5 mM mercaptoethanol at 30°C. 
Initial rates were determined from analysis of time courses of 
the reactions. 
Thus, while it is clear that HIV-2 proteinase has 
a similar topography in its active site cleft to that 
of the enzyme from HIV-1, nevertheless, small but 
significant differences in the respective interactions 
with substrate and inhibitors can be readily 
distinguished. 
From the 3-dimensional structure of the HIV-1 
enzyme [2] it was predicted which residues in the 
enzyme might make contact with residues in in- 
dividual positions in a substrate or inhibitor [2,3]. 
Comparison of the HIV-1 and HIV-2 (predicted) 
amino acid sequences [5] indicates that, with the 
exception of 3 conservative r placements (two Val 
--, lie; one Leu ~ Met), all of these (presumed) 
contact residues are identical in the two enzymes. 
Thus, molecular explanation of the interaction of 
substrates/inhibitors with the active sites of the 
two enzymes are subject o further considerations, 
possibly for example in the positioning of the two 
subunits which comprise the catalytic dimer of the 
viral proteinases. Subtle changes in specificity may 
also result from spatial reorientation of the con- 
served contact residues by changes in adjacent 
residues in either linear or spatial terms. However, 
the finding that the enzymes from HIV-1 and 
HIV-2 are both (relatively) susceptible to inhibi- 
tion by the acetyl-derivative of pepstatin which 
contains the acetyl moiety in the P4 position is ex- 
actly in keeping with the structural findings that a 
Table 2 
Inhibitory constants for the interaction of acetyl-pepstatin a d 
H-261 with HIV-2 proteinase at several pH values 
pH Ki (nM) 
Acetyl-pepstatin H-261 
4.7 5 35 
6.0 10 90 
7.0 750* > 1000" 
Reactions were carried out at the three pH values as described 
in the legend to table 1. The Ki values given at pH 4.7 and 6.0 
are the means of at least three separate determinations. The 
estimated precision for each was in the range + 30°7o. At pH 
7.0, the value given (*) for acetyl-pepstatin s an ICso 
determined at a substrate concentration f 127/zM (because of 
the essentially linear dependence of v with [S] at this pH). 
Similarly, for H-261 at pH 7.0, only 40070 inhibition was 
observed at a [H-261] = l/~M under these conditions 
smaller esidue would bind preferentially in the $4 
position [3]. It would seem feasible that a single in- 
hibitor would be effective towards both viral en- 
zymes and that such a potentially therapeutic 
inhibitor should contain an acetyl moiety in P4 (if 
indeed such a large inhibitor should be necessary). 
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